Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]
Gao J, Iwamoto H, Koskela J, et al. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11: 2457–2465. On page 2457, Abstract, line 3, the text “To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxida...
Main Authors: | Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, Laitinen T, Mazur W, Pulkkinen V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-04-01
|
Series: | International Journal of COPD |
Online Access: | https://www.dovepress.com/erratum-httpswwwdovepresscomcharacterization-of-sputum-biom-peer-reviewed-article-COPD |
Similar Items
-
Characterization of sputum biomarkers for asthma–COPD overlap syndrome
by: Gao J, et al.
Published: (2016-09-01) -
Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap
by: Gao J, et al.
Published: (2017-09-01) -
Heterogeneity of asthma–COPD overlap syndrome
by: Joo H, et al.
Published: (2017-02-01) -
Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations
by: Tamada T, et al.
Published: (2015-10-01) -
Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap
by: Chie Morimoto, MD, PhD, et al.
Published: (2024-02-01)